Drug Shortage Report for ZOLEDRONIC ACID FOR INJECTION
Report ID | 117593 |
Drug Identification Number | 02407639 |
Brand name | ZOLEDRONIC ACID FOR INJECTION |
Common or Proper name | ZOLEDRONIC ACID FOR INJECTION 0.8MG/ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ZOLEDRONIC ACID |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5ml |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-06-10 |
Estimated end date | |
Actual end date | 2020-06-30 |
Shortage status | Resolved |
Updated date | 2023-10-03 |
Company comments | Item is to be discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-10-03 | English | Compare |
v5 | 2021-05-06 | French | Compare |
v4 | 2021-05-06 | English | Compare |
v3 | 2020-06-11 | French | Compare |
v2 | 2020-06-11 | English | Compare |
v1 | 2020-06-11 | English | Compare |
Showing 1 to 6 of 6